BBR Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
BBR Partners's AMGN Position: Q1 2026 in Review
BBR Partners reduced its Amgen (AMGN) stake by 21% in Q1 2026, selling an estimated $537K and leaving 5,580 shares worth $1.96M. The position accounts for 0.11% of the portfolio, ranked #75.
BBR Partners first reported a position in AMGN in Q3 2020 and has held it in 19 quarters since. The position peaked at $2.32M in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- BBR Partners held 5,580 shares of Amgen worth $1.96M as of Q1 2026.
- BBR Partners sold 1,505 Amgen shares in Q1 2026, an estimated $537K.
- Amgen made up 0.11% of BBR Partners's portfolio in Q1 2026, its #75 holding.
- BBR Partners first reported a position in Amgen in Q3 2020 and has held it in 19 quarters since.
- BBR Partners's Amgen position peaked at $2.32M in Q4 2025.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on BBR Partners's 13F filing for Q1 2026, filed 12 May 2026.